| Sep 11 |
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
|
| Sep 11 |
Novartis lower as BofA downgrades on risks to valuation
|
| Sep 11 |
Novartis shares slide on BofA downgrade
|
| Sep 9 |
Travere Gains 11% on Securing Full FDA Nod for Kidney Disease Drug
|
| Sep 6 |
After failed FSGS bid, Travere wins full FDA approval for Filspari in IgAN
|
| Sep 6 |
Novartis to License VYGR's Capsid for Gene Therapy in Neurology
|
| Sep 6 |
Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise
|
| Sep 5 |
Jim Cramer Says It Will Take Time For Novartis AG (NVS) To ‘Get The Attention Of Investors’
|
| Sep 5 |
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
|
| Sep 5 |
Novartis licenses gene therapy component from Voyager
|
